It is with great regret that we in the Geoffrey Jefferson Brain Research Centre join others in acknowledging the recent death of Professor Tipu Aziz.
Category: News
World’s 1st human graphene-based brain computer interface procedure at Salford Royal
The clinical investigation study was conducted at Salford Royal Hospital, part of Northern Care Alliance NHS Foundation Trust in Manchester, UK. The study was led by Chief Clinical Investigator Dr David Coope, a neurosurgeon at the Manchester Centre for Clinical Neuroscience and Brain Tumours Theme Lead at the Geoffrey Jefferson Brain Research Centre, and Chief Scientific Investigator Kostas Kostarelos, PhD, Professor of Nanomedicine at The University of Manchester, the Catalan Institute of Nanoscience & Nanotechnology, and Co-Founder of INBRAIN.
Navigating brain tumour diagnosis: innovations and strategies conference
Our centre was proud to sponsor and attended an event in Manchester that bought together brain tumour experts from across the UK to discuss innovative ways to improve brain tumour diagnosis nationally.
Doctoral Training Centre for Vascular and Immune contributors to dementia
The University of Manchester is the lead institute of a prestigious Alzheimer’s Society-funded Doctoral Training Centre award. A total of £2.9M has been awarded to fund the training and development of 29 PhD students over the next 8 years.
Congratulations to Dr Marilena Hadjidemetriou awarded £1.28m ERC Starting Grant
The NanoNeuroOmics project aims to bridge the gap between brain pathophysiology and molecular changes in the blood, focusing on two of the most challenging central nervous system disorders: Alzheimer’s disease (AD) and Glioblastoma (GBM).
Pioneering bedside genetic test for stroke to undergo further clinical evaluation
An innovative bedside genetic test being implemented in Manchester could dramatically improve outcomes for thousands of people in the UK affected by stroke each year. The test can tell healthcare professionals in approximately one hour if stroke patients will be more likely to benefit from clopidogrel, the current first-line treatment to prevent recurrence.
New trial of an anti-inflammatory antibiotic for pneumonia in people with a stroke
An antibiotic with anti-inflammatory properties will be trialed in 45 stroke units across the UK starting in early 2025. The trial, led by Professor Craig Smith will determine whether this additional treatment will improve clinical and health economic outcomes.
Imaging test to detect and monitor inflammation in brain tumours takes a step forward
Work on an imaging test to detect and monitor inflammation in brain tumours will take a step forward thanks to two new grants. Researchers within our brain imaging theme are developing a clinically applicable imaging test that could be used in all magnetic resonance imaging (MRI) scanners to help predict tumour growth and guide treatment.
First in vivo evidence of increased TSPO expression and inflammation in brains of patients with growing sporadic vestibular schwannomas
Scientists from our brain tumour theme along with colleagues from the Manchester Centre for Clinical Neurosciences, part of Northern Care Alliance NHS Foundation Trust have published a paper in Neuro-Oncology Advances. It is the first in vivo evidence of increased TSPO expression and inflammation within the brains of patients with growing sporadic vestibular schwannomas.
Major funding for heart and stroke research
Manchester is one of nine leading universities which will benefit from a record £35 million funding injection from the British Heart Foundation (BHF) to help strengthen world-leading cardiovascular disease research in the UK. The funding comes from the highly competitive Research Excellence Awards funding scheme.
Address
Geoffrey Jefferson Brain Research Centre
Clinical Sciences Building
Northern Care Alliance
NHS Foundation Trust
Salford
M6 8FJ
Email: GJBRC@manchester.ac.uk
Connect with us
Recent Comments